Evidence map›Paper›PMID 33429812›Full record

ArticleMedicine2021

Impact of lifestyle education for type 2 diabetes mellitus: Protocol for a randomized controlled trial.

Jingjing Zhu, Min Chen, Yuzi Pang, Shumin Li

Expression of concernOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in Medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It carries an expression of concern. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Education programmes for people with chronic kidney disease and diabetes.The Cochrane database of systematic reviews · 2024
    Pooled it
  2. Article
  3. Article
  4. Epicatechin Isolated fromAntioxidants (Basel, Switzerland) · 2024
    Article
  5. Article
  6. Research progress of extracellular vesicles in type 2 diabetes and its complications.Diabetic medicine : a journal of the British Diabetic Association · 2022
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 4 countries.

Jingjing ZhuDepartment of Endocrinology, Ningbo No.6 hospital, Zhejiang, China.
Min Chen
Yuzi Pang
National Natural Science Foundation of China · CNNingbo No. 2 Hospital · CN

Funding

National Natural Science Foundation of China 81779031
6 · The paper itself

Abstract

objectiveTo explore the influence of the education of lifestyle in the type 2 diabetes mellitus (T2DM) patients with microalbuminuria as a part of the enhanced multifactorial intervention.

methodsThis study will be conducted from May 2021 to August 2022 at Ningbo No.6 hospital. The experiment was granted through the Research Ethics Committee of Ningbo No.6 hospital (539D035). The patients will be included if they are between 18 and 65 years old and are diagnosed with T2DM with microalbuminuria and the patients who have signed the written informed consent. While the patients will be excluded if they have serious physical comorbidities and patients who are unwilling to offer the informed consent to take part in this experiment. We measure the clinical examination (fasting blood-glucose, glycosylated hemoglobin and routine urine test) timely. Detail of daily dietary intake and lifestyle factors are also recorded.

resultsTable 1 reflects the comparison of the biochemical and clinical variables and the lifestyle factors.

conclusionLifestyle education is effective in facilitating the control of T2DM and reducing microalbuminuria. TRIAL REGISTRATION NUMBER: researchregistry6348.

Indexed as

Patient Education as TopicRisk-TakingAlbuminuriaDiabetes Mellitus, Type 2HumansRandomized Controlled Trials as Topic

Identifiers

PMID33429812
PMCPMC7793339
OpenAlexW3119062264

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.